Contact Levi & Korsinsky by October 20, 2025 to Join Class Action Against Snap Inc. (SNAP)
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your Snap Inc. (NYSE: SNAP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/snap-inc-lawsuit-submission-form-2?prid=170765&wire=5&utm_campaign=10 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-10-03 4:38 PM EDT
Lost Money on PubMatic, Inc. (PUBM)? Urged to Join Class Action Before October 20, 2025 - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your PubMatic, Inc. (NASDAQ: PUBM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pubmatic-inc-lawsuit-submission-form?prid=170764&wire=5&utm_campaign=22 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-10-03 4:35 PM EDT
Join Class Action to Recover Losses from Altimmune, Inc. (ALT) - Contact Levi & Korsinsky Before October 6, 2025
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your Altimmune, Inc. (NASDAQ: ALT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/altimmune-inc-lawsuit-submission-form-2?prid=170763&wire=5&utm_campaign=31 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder...
2025-10-03 4:33 PM EDT
October 25, 2025 Deadline Approaching: Join Class Action Against LifeMD, Inc. (LFMD) - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your LifeMD, Inc. (NASDAQ: LFMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lifemd-inc-lawsuit-submission-form?prid=170762&wire=5&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-10-03 4:24 PM EDT
Levi & Korsinsky Notifies Dow Inc. (DOW) Investors - Lead Plaintiff Deadline on October 28, 2025
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your Dow Inc. (NYSE: DOW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dow-inc-lawsuit-submission-form?prid=170761&wire=5&utm_campaign=14 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-10-03 4:22 PM EDT
Levi & Korsinsky Urges Semler Scientific, Inc. (SMLR) Shareholders to Act Before Lead Plaintiff Deadline October 28, 2025
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your Semler Scientific, Inc. (NASDAQ: SMLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/semler-scientific-inc-lawsuit-submission-form?prid=170760&wire=5&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced...
2025-10-03 3:56 PM EDT
Investigation Underway: MoonLake Immunotherapeutics (MLTX) - Contact Levi & Korsinsky Over Securities Law Violations
New York, New York--(Newsfile Corp. - October 3, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of MoonLake Immunotherapeutics ("MoonLake") (NASDAQ: MLTX) concerning possible violations of federal securities laws. On September 29, 2025, MoonLake announced that its experimental immune disease drug sonelokimab for the treatment of a chronic inflammatory skin condition, hidradenitis suppurativa, failed to meet that one of its late-stage trials. Specifically,...
2025-10-03 3:54 PM EDT
Class Action Alert: Levi & Korsinsky Reminds Charter Communications, Inc. (CHTR) Investors of October 14, 2025 Deadline
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your Charter Communications, Inc. (NASDAQ: CHTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/charter-communications-inc-lawsuit-submission-form?prid=170758&wire=5&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of...
2025-10-03 3:53 PM EDT
Investors in Fly-E Group, Inc. (FLYE): Protect Your Rights - Contact Levi & Korsinsky Before November 10, 2025
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your Fly-E Group, Inc. (NASDAQ: FLYE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fly-e-group-inc-lawsuit-submission-form?prid=170615&wire=5&utm_campaign=11 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder...
2025-10-03 9:11 AM EDT
Lost Money on C3.ai, Inc. (AI)? Contact Levi & Korsinsky to Join Class Action Before October 21, 2025
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your C3.ai, Inc. (NYSE: AI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/c3-ai-inc-lawsuit-submission-form?prid=170614&wire=5&utm_campaign=20 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-10-03 9:07 AM EDT
Levi & Korsinsky Urges Fortinet, Inc. (FTNT) Shareholders to Act Before Lead Plaintiff Deadline November 21, 2025
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your Fortinet, Inc. (NASDAQ: FTNT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fortinet-inc-lawsuit-submission-form?prid=170613&wire=5&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-10-03 9:03 AM EDT
Investigation Opened on Behalf of Firefly Aerospace Inc. (FLY) Shareholders - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - October 3, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Firefly Aerospace Inc. ("Firefly Aerospace Inc.") (NASDAQ: FLY) concerning possible violations of federal securities laws. On or around August 7, 2025, Firefly conducted an initial public offering of 19.3 million shares of common stock priced at $45.00 per share. Then, on September 23, 2025, Firefly reported its financial results for the second quarter of...
2025-10-03 8:23 AM EDT
Securities Class Action Lawsuit Filed Against V.F. Corporation (VFC) - Levi & Korsinsky Represents Shareholders
New York, New York--(Newsfile Corp. - October 1, 2025) - If you suffered a loss on your V.F. Corporation (NYSE: VFC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/v-f-corporation-lawsuit-submission-form?prid=170490&wire=5&utm_campaign=13 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder...
2025-10-01 4:56 PM EDT
ATTENTION MLTX Shareholders: Lost Money on MoonLake Immunotherapeutics? Contact Levi & Korsinsky About Investigation
New York, New York--(Newsfile Corp. - October 1, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of MoonLake Immunotherapeutics ("MoonLake") (NASDAQ: MLTX) concerning possible violations of federal securities laws. On September 29, 2025, before the market opened, MoonLake filed with the SEC a current report on Form 8-K. Attached to the current report was a press release which stated that, in MoonLake's VELA-2 trial, "intercurrent events in the...
2025-10-01 4:55 PM EDT
Securities Fraud Class Action Filed Against Charter Communications, Inc. (CHTR) - Levi & Korsinsky Reminds Investors of October 14, 2025
New York, New York--(Newsfile Corp. - October 1, 2025) - If you suffered a loss on your Charter Communications, Inc. (NASDAQ: CHTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/charter-communications-inc-lawsuit-submission-form?prid=170488&wire=5&utm_campaign=27 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of...
2025-10-01 4:27 PM EDT
Levi & Korsinsky Urges Fortinet, Inc. (FTNT) Shareholders to Act Before Lead Plaintiff Deadline November 21, 2025
New York, New York--(Newsfile Corp. - October 1, 2025) - If you suffered a loss on your Fortinet, Inc. (NASDAQ: FTNT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fortinet-inc-lawsuit-submission-form?prid=170486&wire=5&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-10-01 4:22 PM EDT
Ongoing Valneva SE (VALN) Investigation: Protect Your Rights - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - October 1, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Valneva SE ("Valneva SE") (NASDAQ: VALN) concerning possible violations of federal securities laws. On August 25, 2025, before the market opened, Valneva announced that the FDA suspended the license for its chikungunya vaccine IXCHIQ due to new reports of serious adverse events consistent with chikungunya-like illness. The suspension is effective immediately...
2025-10-01 4:20 PM EDT
Levi & Korsinsky Launches Fraud Investigation on Behalf of EHang Holdings Limited (EH) Shareholders
New York, New York--(Newsfile Corp. - October 1, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of EHang Holdings Limited ("EHang Holdings Limited") (NASDAQ: EH) concerning possible violations of federal securities laws. EHang reduced its 2025 revenue projection to 500 million yuan from 900 million yuan, prompting Morgan Stanley to lower its forecasts for the Company on August 26, 2025. Following this news, EHang's American Depositary Receipt ("ADR") price...
2025-10-01 4:19 PM EDT
Lost Money on Slide Insurance Holdings, Inc. (SLDE)? Contact Levi & Korsinsky to Protect Your Rights
New York, New York--(Newsfile Corp. - October 1, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Slide Insurance Holdings, Inc. ("Slide") (NASDAQ: SLDE) concerning possible violations of federal securities laws. On September 30, 2025, a Manatee Research report alleged Slide's underwriting margins are driven by claim denials and delays, rather than the "proprietary technology" previously touted by the company. The report also claims that Florida regulators...
2025-10-01 4:18 PM EDT
Did Tandem Diabetes Care, Inc. (TNDM) Mislead Investors? Levi & Korsinsky Investigates
New York, New York--(Newsfile Corp. - October 1, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Tandem Diabetes Care, Inc. ("Tandem Diabetes Care, Inc.") (NASDAQ: TNDM) concerning possible violations of federal securities laws. Tandem disclosed on August 7, 2025, that a malfunction had been identified in some of its insulin pumps, which could "trigger an error resulting in a discontinuation of insulin delivery," which "could result in hyperglycemia due...
2025-10-01 4:17 PM EDT